Baxter acquires Gambro renal dialysis products company
Baxter Enhances Renal Therapies Portfolio with Acquisition of Gambro — Acquisition Expands Baxter’s Role as Global Provider of Dialysis Products – Baxter International Inc. (NYSE:BAX) has entered into a definitive agreement to acquire Gambro AB, a privately held dialysis product company based in Lund, Sweden, for total consideration of 26.5 billion SEK (approximately $4.0 billion USD at current exchange rates).